| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.67M | 4.87M | 2.05M | 16.89M | -1.20M |
| Gross Profit | 18.67M | 4.87M | 2.05M | 16.89M | -1.20M |
| EBITDA | 18.67M | -3.43K | 2.05M | 19.09M | -1.20M |
| Net Income | 18.67M | 4.86M | 2.05M | 19.09M | -1.20M |
Balance Sheet | |||||
| Total Assets | 115.03M | 101.38M | 102.42M | 105.40M | 97.73M |
| Cash, Cash Equivalents and Short-Term Investments | 140.04K | 133.99K | 129.15K | 128.55K | 128.61K |
| Total Debt | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K |
| Total Liabilities | 140.04K | 133.99K | 125.00K | 125.00K | 125.00K |
| Stockholders Equity | 114.89M | 101.24M | 102.29M | 105.27M | 97.60M |
Cash Flow | |||||
| Free Cash Flow | 5.03M | 5.91M | 5.03M | 11.42M | 836.98K |
| Operating Cash Flow | 5.03M | 5.91M | 5.03M | 11.42M | 836.98K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | -5.03M | -5.91M | -5.03M | -11.42M | -836.74K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ― | 1.10 | ― | 4.96% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | £18.46M | 4.02 | 16.48% | ― | -79.36% | 78.16% | |
48 Neutral | £1.45M | -2.93 | -37.63% | ― | -100.66% | 84.15% | |
48 Neutral | £4.50M | -1.85 | -12.33% | ― | ― | ― | |
44 Neutral | £14.09M | -19.81 | -21.85% | ― | ― | ― | |
40 Underperform | $1.02M | -0.04 | ― | ― | -96.59% | 93.69% |
Marwyn Value Investors Limited has declared an interim dividend of 2.265p per ordinary share, to be paid on 27 February 2026 under its ordinary share distribution policy. The dividend will be settled electronically via CREST or BACS, with an ex-dividend date of 5 February and a record date of 6 February, and shareholders whose holdings are not CREST-settled are instructed to register bank details with the company’s registrar to ensure smooth, chequeless payment, underscoring the company’s continued commitment to cash returns for investors and fully electronic dividend settlement.
The most recent analyst rating on (GB:MVI) stock is a Buy with a £164.00 price target. To see the full list of analyst forecasts on Marwyn Value Investors stock, see the GB:MVI Stock Forecast page.
Marwyn Value Investors Limited disclosed that independent non-executive director Peter Rioda has transferred 10,000 ordinary shares between his own broker accounts, a move that does not alter his overall beneficial holding in the company, which remains at 30,000 ordinary shares, or roughly 0.05% of voting rights. The company reiterated that its shares are not designed or promoted for retail investors, underscoring its focus on institutional and professional shareholders and signalling no change to its capital structure or governance from this internal share account transfer.
The most recent analyst rating on (GB:MVI) stock is a Buy with a £161.00 price target. To see the full list of analyst forecasts on Marwyn Value Investors stock, see the GB:MVI Stock Forecast page.
Marwyn Value Investors has disclosed that Marwyn employees have purchased 37,761 ordinary shares in the company from Marwyn Capital Management Limited at 135.69p per share, matching MCML’s original acquisition cost in October. Following the transaction, Chief Investment Officer James Corsellis and his wholly owned entity MCML together hold 6,933,872 ordinary shares, representing about 12.26% of the company’s voting rights, and while neither is formally classified as a PDMR, both the manager and the company have chosen to report the dealings to the market on a voluntary, PDMR-equivalent basis, underscoring a stance of heightened governance transparency for investors.
Marwyn Value Investors has disclosed that independent non-executive director Peter Rioda has increased his stake in the company by purchasing 10,000 ordinary shares at a price of £1.3807 per share. Following the transaction, executed on the London Stock Exchange, Rioda now holds 30,000 shares, representing approximately 0.05% of the company’s voting rights, a move that signals board-level confidence while remaining a relatively small position in the overall share capital.